$MRSH

Marsh & McLennan tops second-quarter forecasts as demand drives revenue growth (MRSH)

Marsh & McLennan (NYSE:MRSH) reported Q2 adjusted EPS of $2.96, above the $2.90 consensus, and revenue of $7.4 billion versus $7.28 billion expected. Revenue rose 6% year over year. Adjusted operating income increased 5% to $2.2 billion. The company repurchased 4.5 million shares for about $750 million and raised its quarterly dividend to $0.990.

Original reporting
Published Jul 23, 2026, 1:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 23, 2026, 1:37 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Marsh & McLennan tops second-quarter forecasts as demand drives revenue growth (MRSH) — source image
Decision brief

The 30-second read

$MRSHBullishMed
01

Why it matters

The beat on both adjusted EPS and revenue, alongside operating profit growth and a higher dividend plus large buyback, creates a near-term catalyst for MRSH positioning. Segment detail shows consulting strength but a decline at Guy Carpenter, which could influence how traders price durability of growth.

02

Market read

Fresh earnings datapoints and capital return actions can drive immediate repricing versus consensus, especially given the pre-market share move.

03

What to watch

Underlying growth is cited, but the article does not provide guidance or margin outlook; buyback and dividend support may mask slower momentum in specific sub-segments.

Relevance 8/10Novelty 8/10Timing: pre-market reaction after Q2 results release

Background

Marsh & McLennan reported second-quarter results, framing performance around demand across risk, people, strategy, and investments.

Company-level read

Ticker impact

$MRSHBullishMedium confidence
Context

Marsh & McLennan beat Q2 estimates with adjusted EPS of $2.96 vs $2.90 and revenue of $7.4B vs $7.28B.

Expected impact

Shares may extend gains if investors focus on demand strength and consulting growth, though the Guy Carpenter decline could limit follow-through.

Evidence & confidence

The article provides fresh, quantified Q2 results, including EPS, revenue, operating income growth, and a dividend increase plus large buyback, which are actionable for positioning. However, it also notes Guy Carpenter revenue declined 2%, adding offsetting detail.

Market effects

Supports the broader insurance brokerage and consulting demand narrative, with consulting identified as the fastest-growing division.

Highlights underlying growth in the U.S. and Canada (Marsh Risk +4% underlying) and international markets (+5% underlying).

Reinforces global risk and people advisory demand, with international growth contributing to segment performance.

Counterpoint

The headline beat may be partially offset by weakness in Guy Carpenter, suggesting investors should not extrapolate uniformly across all brokerage lines.

Key entities

  • Marsh & McLennan Companies

    Reported Q2 adjusted EPS of $2.96 and revenue of $7.4B, with operating income up 5% and shareholder returns via buybacks and a dividend increase.

Related articles

$MRSHMed

Marsh & McLennan Companies Q2 Earnings Call Highlights

Marsh & McLennan (NYSE:MRSH) reported Q2 results and discussed market conditions on its earnings call. Consulting revenue rose 10% to $2.6B, with adjusted operating income up 11% to $533M. Mercer revenue was $1.6B. Marsh Global Insurance Market Index showed primary commercial rates down 6% in Q2. The company ended with $20.6B debt and $1.7B cash, and expects $5.5B capital deployment in 2026.

$MRSHMed

Marsh (NYSE:MRSH) Exceeds Q2 CY2026 Expectations

Marsh (NYSE:MRSH) reported Q2 CY2026 results. Revenue rose 6.2% year on year to $7.40 billion, exceeding Wall Street’s estimate by 1.8%, and non-GAAP EPS was $2.96, 2.3% above consensus. Adjusted operating margin was 26.9%. Analysts expect revenue growth of 4.2% and full-year EPS to rise from $10.22 to $10.90.

$MRSHMed

MARSH & MCLENNAN COMPANIES, INC. (MRSH): Results of Operations and Financial Condition

MARSH & MCLENNAN COMPANIES, INC. (MRSH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 mmc2q2026ex991newsrelease.htm PRESS RELEASE JUNE 30, 2026 Document Marsh 212 345 5000 www.corporate.marsh.com News release Exhibit 99.1 Marsh reports second quarter 2026 results • Revenue Growth of 6%; Underlying Revenue Growth of 5% • GAAP Operating Income Increases 4%

$MRSHHighAI 9/10

Marsh & McLennan Companies (NYSE:MRSH) Stock Price Down 13.1% After Analyst Downgrade

Marsh & McLennan (NYSE:MRSH) fell 13.1% mid-day Wednesday after Piper Sandler cut its price target to $182 from $190 and kept a neutral rating. Shares traded as low as $180.97 and last at $160.70, after closing $185.00; volume rose to 3.04M. The article also cites recent analyst target changes and April 16 quarterly results: $3.29 EPS vs $3.21 consensus on $7.30B revenue.

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.